Biotech Investors & VC Firms in United States
1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.
XSeed Capital
Menlo ParkPre-Seed–Late Stage
6 people
Good Ventures
Seed
2 people
BioRock Ventures
San FranciscoPre-Seed–Late Stage
1 person
Curative Ventures
Dallas
1 person
Paragon Biosciences LLC
ChicagoSeed–Series A
1 person
MB Venture Partners
MemphisPre-Seed–Late Stage
2 people
TCG Labs
San Francisco
2 people
venture / science
San Francisco Bay AreaSeed–Late Stage
2 people
Curious Office Partners
BoiseSeed
1 person
Nimble Ventures
San FranciscoSeed–Series B
1 person
Trans-it Capital
Palo AltoSeed
1 person
View Ventures
DallasPre-Seed–Series A
1 person
Aceleradora Litoral
Santa FePre-Seed–Series A$500K
Camford Capital
Menlo ParkPre-Seed–Series A
8 people
EQx Fund
BostonPre-Seed–Late Stage
1 person
Pura Vida Investments
New YorkLate Stage
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Dalena Capital
Palo AltoSeed
2 people
Ginkgo Bioworks
Boston
2 people
Helaina
New York
2 people
PFM Health Sciences
San FranciscoPre-Seed–Series A
2 people
Riverine Ventures
Sausalito
2 people
StarChain Ventures
Silicon ValleyPre-Seed–Series B
2 people
Swift Street Capital
DurhamSeed–Series A
2 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.




























